In Situ Erosion Study to Investigate the Effectiveness of an Experimental Toothpaste
A Randomized, Examiner Blind, Crossover, in Situ Erosion Study to Investigate the Efficacy of an Experimental Dentifrice in Remineralization of Previously Softened Enamel Compared to a Placebo Dentifrice
Sponsor: GlaxoSmithKline
Listed as NCT03296072, this PHASE3 trial focuses on Tooth Erosion and remains completed. Sponsored by GlaxoSmithKline, it has been updated 11 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE3
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE3
▶ Show 6 earlier versions
-
Oct 2020 — Jan 2021 [monthly]
Completed PHASE3
Phase: PHASE2_PHASE3 → PHASE3
-
Mar 2019 — Oct 2020 [monthly]
Completed PHASE2_PHASE3
Phase: PHASE3 → PHASE2_PHASE3
-
Jun 2018 — Mar 2019 [monthly]
Completed PHASE3
-
Feb 2018 — Jun 2018 [monthly]
Completed PHASE3
Status: Recruiting → Completed
-
Dec 2017 — Feb 2018 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Oct 2017 — Dec 2017 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- GlaxoSmithKline
For direct contact, visit the study record on ClinicalTrials.gov .